Katzer et al. recently proposed that estrogen-mediated dysregulation of lower body fat accumulation in lipedema might be explained by a higher ERα/ERβ ratio or an increased production of steroidogenic enzymes, such as aromatase, leading to paracrine signaling and ERα activation among local adipocytes [12]. This evidence concerns the gene CYP19A1 and Lipedema.